INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 43h ago
House PTR3h ago
SEC 13F3h ago
Robinhood Chain3h ago

Most active filers · 30d

  1. 01Kurtz George0B / 204S204 trades$51.20M
  2. 02SPSaba Capital Management, L.P.70B / 21S · 11 late91 trades$26.34M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04AJAllaire Jeremy0B / 50S50 trades$4.26M
  5. 05Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  6. 06SJSheena Jonathan0B / 43S43 trades$3.14M
  7. 07SLSpeiser Michael L0B / 35S35 trades$14.00M
  8. 08RARothblatt Martine A0B / 33S33 trades$5.50M
  9. 09RJRubinstein Julie0B / 33S33 trades$5.33M
  10. 10CECrimmins David Edward0B / 31S31 trades$723K

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 108 insiders$40.91M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  7. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  8. SELLULCCFrontier Group Holdings, Inc.Nov 5 – Nov 117 insiders$1.31M

Form 4 transactions

68,650 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
35
VC
Van Tuyl ChristopherChief Legal Officer
IMVTImmunovant, Inc.
Open-market sale
SELL$111K
2,842 sh
Jun 26, 2026Jun 26, 2026
Page 606 of 1717
← PrevNext →
traded Jun 26, 2026
+0d
SEC Form 4

Evidence

35
SS
Stout Jay SChief Technology Officer
IMVTImmunovant, Inc.
Open-market sale
SELL$262K
6,723 sh
Jun 26, 2026Jun 26, 2026
traded Jun 26, 2026
+0dSEC Form 4

Evidence

34
SC
Stephenson Brian CChief Financial Officer
FTHFaeth Therapeutics, Inc.
Open-market purchase
BUY$73K
2,891 sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

34
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$1.69M
16.4K sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

34
SC
Stephenson Brian CChief Financial Officer
FTHFaeth Therapeutics, Inc.
Open-market purchase
BUY$105K
4,212 sh
Jun 26, 2026Jun 26, 2026
traded Jun 26, 2026
+0dSEC Form 4

Evidence

34
SC
Stephenson Brian CChief Financial Officer
FTHFaeth Therapeutics, Inc.
Open-market purchase
BUY$92K
3,400 sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

34
SC
Stephenson Brian CChief Financial Officer
FTHFaeth Therapeutics, Inc.
Open-market purchase
BUY$78K
3,000 sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

33
ST
Smokoff TimothyDirector
VMDVIEMED HEALTHCARE, INC.
Open-market sale
SELL$57K
5,000 sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

33
ST
Smokoff TimothyDirector
VMDVIEMED HEALTHCARE, INC.
Open-market sale
SELL$58K
5,000 sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

33
ST
Smokoff TimothyDirector
VMDVIEMED HEALTHCARE, INC.
Open-market sale
SELL$58K
5,000 sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

33
FW
Frazier WilliamDirector, Chief Medical Officer
VMDVIEMED HEALTHCARE, INC.
Open-market sale
SELL$117K
10.0K sh
Jun 25, 2026Jun 26, 2026
traded Jun 25, 2026
+1dSEC Form 4

Evidence

32
BM
Bendza Gary MarkEVP, CFO
TLSTELOS CORP
Open-market sale
SELL$411K
98.0K sh
Jun 25, 2026Jun 26, 2026
traded Jun 25, 2026
+1dSEC Form 4

Evidence

32
BM
Bendza Gary MarkEVP, CFO
TLSTELOS CORP
Open-market sale
SELL$313K
71.9K sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

32
BM
Bendza Gary MarkEVP, CFO
TLSTELOS CORP
Open-market sale
SELL$353K
80.1K sh
Jun 26, 2026Jun 26, 2026
traded Jun 26, 2026
+0dSEC Form 4

Evidence

31
MM
Mindlin Marcos MarceloDirector, 10% Owner
PAMPampa Energy Inc.
Open-market purchase
BUY$2.48M
739.2K sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

31
FA
Fang AndyDirector
DASHDoorDash, Inc.
Open-market sale · 10b5-1 plan
SELL$900K
5,000 sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

31
MM
Mindlin Marcos MarceloDirector, 10% Owner
PAMPampa Energy Inc.
Open-market purchase
BUY$1.29M
383.6K sh
Jun 25, 2026Jun 26, 2026
traded Jun 25, 2026
+1dSEC Form 4

Evidence

31
AA
Aden AllisonEVP, CFO & Treasurer
CVCOCAVCO INDUSTRIES, INC.
Open-market sale
SELL$921K
1,473 sh
Jun 25, 2026Jun 26, 2026
traded Jun 25, 2026
+1dSEC Form 4

Evidence

31
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$423K
4,112 sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

30
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$1.26M
12.7K sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

30
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$1.64M
16.2K sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

29
RB
Rhame Joseph Burns IIIOfficer of Investment Advisor
UTGREAVES UTILITY INCOME FUND
Open-market purchase
BUY$21K
500 sh
Jun 26, 2026Jun 26, 2026
traded Jun 26, 2026
+0dSEC Form 4

Evidence

29
SE
Smolyansky Edward10% Owner
LWAYLifeway Foods, Inc.
Open-market sale
SELL$55K
1,793 sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

28
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$62K
602 sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

28
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$250K
2,410 sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

27
BL
Burrows Scott LChief Financial Officer
SYRESpyre Therapeutics, Inc.
Open-market sale
SELL$871K
10.0K sh
Jun 25, 2026Jun 26, 2026
traded Jun 25, 2026
+1dSEC Form 4

Evidence

27
RB
Rhame Joseph Burns IIIOfficer of Investment Advisor
UTGREAVES UTILITY INCOME FUND
Other acquisition or disposition
J$1,909
50 sh
Jan 31, 2026Jun 26, 2026
traded Jan 31, 2026
+146dSEC Form 4

Evidence

27
WP
Wierbicki PaulDirector, Chief Legal Officer
RSIRush Street Interactive, Inc.
Open-market sale
SELL$301K
10.0K sh
Jun 25, 2026Jun 26, 2026
traded Jun 25, 2026
+1dSEC Form 4

Evidence

27
RB
Rhame Joseph Burns IIIOfficer of Investment Advisor
UTGREAVES UTILITY INCOME FUND
Other acquisition or disposition
J$1,971
46 sh
Apr 30, 2026Jun 26, 2026
traded Apr 30, 2026
+57dSEC Form 4

Evidence

27
RB
Rhame Joseph Burns IIIOfficer of Investment Advisor
UTGREAVES UTILITY INCOME FUND
Other acquisition or disposition
J$1,917
46 sh
Feb 28, 2026Jun 26, 2026
traded Feb 28, 2026
+118dSEC Form 4

Evidence

27
RB
Rhame Joseph Burns IIIOfficer of Investment Advisor
UTGREAVES UTILITY INCOME FUND
Other acquisition or disposition
J$866
23 sh
Jan 31, 2026Jun 26, 2026
traded Jan 31, 2026
+146dSEC Form 4

Evidence

27
RB
Rhame Joseph Burns IIIOfficer of Investment Advisor
UTGREAVES UTILITY INCOME FUND
Other acquisition or disposition
J$869
22 sh
Mar 31, 2026Jun 26, 2026
traded Mar 31, 2026
+87dSEC Form 4

Evidence

27
RB
Rhame Joseph Burns IIIOfficer of Investment Advisor
UTGREAVES UTILITY INCOME FUND
Other acquisition or disposition
J$870
21 sh
Feb 28, 2026Jun 26, 2026
traded Feb 28, 2026
+118dSEC Form 4

Evidence

27
SC
Stephenson Brian CChief Financial Officer
FTHFaeth Therapeutics, Inc.
Open-market purchase
BUY$14K
580 sh
Jun 26, 2026Jun 26, 2026
traded Jun 26, 2026
+0dSEC Form 4

Evidence

27
RB
Rhame Joseph Burns IIIOfficer of Investment Advisor
UTGREAVES UTILITY INCOME FUND
Other acquisition or disposition
J$895
21 sh
Apr 30, 2026Jun 26, 2026
traded Apr 30, 2026
+57dSEC Form 4

Evidence

27
SC
Stephenson Brian CChief Financial Officer
FTHFaeth Therapeutics, Inc.
Open-market purchase
BUY$2,639
100 sh
Jun 26, 2026Jun 26, 2026
traded Jun 26, 2026
+0dSEC Form 4

Evidence

27
RB
Rhame Joseph Burns IIIOfficer of Investment Advisor
UTGREAVES UTILITY INCOME FUND
Other acquisition or disposition
J$1,914
49 sh
Mar 31, 2026Jun 26, 2026
traded Mar 31, 2026
+87dSEC Form 4

Evidence

27
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$410K
4,062 sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

27
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$316K
3,167 sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

27
SC
Stephenson Brian CChief Financial Officer
FTHFaeth Therapeutics, Inc.
Open-market purchase
BUY$2,777
100 sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence